| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3947339 | Gynecologic Oncology | 2017 | 7 Pages |
Abstract
ERCC1 protein overexpression may act as a prognostic marker for poor survival of high-grade OC even in patients operated with residual disease.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Stefanie Scheil-Bertram, Patricia Tylus-Schaaf, Andreas du Bois, Philipp Harter, Matthias Oppitz, Nina Ewald-Riegler, Annette Fisseler-Eckhoff,